Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

A Tuberculosis Contact Investigation on Health Care Workers in One Hospital

일개 병원 내 의료종사자에서의 결핵 접촉자 조사

  • Kim, Tae Hee (Department of Pediatrics, Hanyang University Hospital) ;
  • Jang, Yoon Suk (Department of Infection Control, Hanyang University Hospital) ;
  • Jung, Sun Ju (Department of Infection Control, Hanyang University Hospital) ;
  • Kim, Yeon Jae (Department of Internal Medicine, National Medical Center) ;
  • Pai, Hyun Joo (Department of Internal Medicine, Hanyang University Hospital) ;
  • Oh, Sung Hee (Department of Pediatrics, Hanyang University Hospital)
  • 김태희 (한양대학교병원 소아청소년과) ;
  • 장윤숙 (한양대학교병원 감염관리실) ;
  • 정선주 (한양대학교병원 감염관리실) ;
  • 김연재 (국립중앙의료원 내과) ;
  • 배현주 (한양대학교병원 내과) ;
  • 오성희 (한양대학교병원 소아청소년과)
  • Received : 2015.09.24
  • Accepted : 2015.11.03
  • Published : 2016.08.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study aimed to describe the results of a contact investigation on health care workers after exposure to a house officer with smear-positive pulmonary tuberculosis (TB). Methods: Eighty nine out of 101 subjects who had close contact with the index patient agreed to be enrolled in the investigation. The first contact investigation was conducted approximately 30 days after the index patient's onset of symptoms, followed by the second investigation after 10 weeks. In both, clinical manifestations were studied, and chest X-ray and tuberculin skin test (TST)/QuantiFERON-TB Gold (QFT-G) in dual screening strategy were conducted. Results: The first TST resulted in positive in 34 subjects (38.2%). QFT-G was conducted on 16 subjects who tested positive in the first TST and aged under 36. Six of them (37.5%) were positive. The second TST was conducted on 41 subjects with negative results in the first TST. Seventeen (41.5%) were positive and among them, three (17.6%) showed positive QFT-G. None of the subjects were diagnosed with active TB. The probability of TB infection through contact with the index patient was 7.3% (3/41) in dual screening strategy while it was 41.5% (17/41) in TST strategy. Conclusions: This first hospital-setting contact investigation for tuberculosis in Korea revealed that latent tuberculosis infection (LTBI) rates vary depending on different diagnostic strategies. This indicates the need for systematic guidelines for diagnosing LTBI in health care workers who have professional exposure to TB.

목적: 대학병원에 근무하던 중 활동성 폐결핵으로 진단된 전공의에게 노출된 의료종사자들에 대하여 실시한 접촉자 조사의 결과를 보고한다. 방법: 활동성 폐결핵 환자와 밀접한 접촉을 한 사람(접촉자) 101명 중 89명이 접촉자 조사에 응하여 조사를 받았다. 1차 접촉자 조사는 지표환자의 증상 개시 후 30일경에, 2차 조사는 1차 조사 10주 후에 기침, 발열, 인후통, 체중 감소와 같은 임상증상 확인 및 단순흉부촬영과 함께 결핵반응검사(Tuberculin skin test, TST)/QuantiFERON-TB Gold (QFT-G) 2단계 검사법을 시행하였다. 결과: 1차 TST 양성자는 34명(38.2%)이었고, TST 양성자 중 35세 이하 접촉자에서 시행한 QFT-G 양성률은 37.5% (6/16)이었다. 1차 TST 음성 대상자 41명에게서 시행한 2차 TST에서 17명(41.5%)이 양전을 보였고 그들 중 시행한 QFT-G 검사에서 3명(17.6%)이 양성이었다. 활동성 결핵으로 진단된 접촉자는 없었으며 지표환자에 노출되어 발생한 결핵 전파율은 2단계 검사법으로는 7.3% (3/41)였고, TST 진단법으로는 41.5% (17/41)였다. 결론: 국내에서 처음 보고되는 병원 내 결핵 접촉자 조사 연구로서 LTBI 발생률이 그 진단 기법에 따라 달랐으며 따라서 앞으로 발생할 수 있는 의료종사자들에 대한 병원 내 결핵 접촉자 조사를 위해 조직적이고 실용적인 가이드라인이 필요할 것이다.

Keywords

References

  1. World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization, 2014.
  2. Yang SH, Chu MA, Park HJ, Lee KH, Kim JK, Choi EJ, et al. Clinical characteristics of tuberculosis in school-age children and adolescents at a single institution. Pediatr Allergy Respir Dis 2012;22:239-47. https://doi.org/10.7581/pard.2012.22.3.239
  3. Styblo K. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 1980;20:1-63.
  4. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282:677-86. https://doi.org/10.1001/jama.282.7.677
  5. Shim TS, Koh WJ, Yim JJ, Lew WJ. Treatment of latent tuberculosis infection in Korea. Tuberc Respir Dis 2008;65:79-90. https://doi.org/10.4046/trd.2008.65.2.79
  6. Chen TC, Lu PL, Yang CJ, Lin WR, Lin CY, Jou R, et al. Management of a nosocomial outbreak of Mycobacterium tuberculosis Beijing/W genotype in Taiwan: an emphasis on case tracing with high-resolution computed tomography. Jpn J Infect Dis 2010;63:199-203.
  7. Jonsson J, Kan B, Berggren I, Bruchfeld J. Extensive nosocomial transmission of tuberculosis in a low-incidence country. J Hosp Infect 2013;83:321-6. https://doi.org/10.1016/j.jhin.2012.11.028
  8. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54(RR-17):1-141.
  9. Korea Centers for Disease Control and Prevention. National guidelines for control and prevention of tuberculosis. Osong: Korea Centers for Disease Control and Prevention, 2013.
  10. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2007;11:16-26.
  11. Wrighton-Smith P, Zellweger JP. Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 2006;28:45-50. https://doi.org/10.1183/09031936.06.00005906
  12. Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korean Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 2nd ed. Seoul and Cheongwon: Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention, 2014.
  13. Horsburgh CR Jr. Tuberculosis. Eur Respir Rev 2014;23:36-9. https://doi.org/10.1183/09059180.00008213
  14. Tuberculosis Research Centre, Indian Council of Medical Research, Chennai, India. Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases. Int J Tuberc Lung Dis 2011;15:782-8. https://doi.org/10.5588/ijtld.09.0327
  15. Jo KW, Woo JH, Hong Y, Choi CM, Oh YM, Lee SD, et al. Incidence of tuberculosis among health care workers at a private university hospital in South Korea. Int J Tuberc Lung Dis 2008;12:436-40.
  16. Riva MA, Ploia PR, Rocca S, Cesana G. "Phthisiophobia": the difficult recognition of transmission of tuberculosis to health care workers. Med Lav 2013;104:359-67.
  17. Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 2014;27:3-20. https://doi.org/10.1128/CMR.00034-13
  18. Landry J, Menzies D. Preventive chemotherapy. Where has it got us? Where to go next? Int J Tuberc Lung Dis 2008;12:1352-64.
  19. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-204.
  20. Bugiani M, Borraccino A, Migliore E, Carosso A, Piccioni P, Cavallero M, et al. Tuberculin reactivity in adult BCG-vaccinated subjects: a cross-sectional study. Int J Tuberc Lung Dis 2003;7:320-6.
  21. Mauch H, Brehmer W. Mycobacterial antibodies after tuberculin testing, BCG-vaccination, BCG-immunotherapy and against cross-reacting antigens in a solid-phase radioimmunoassay. Zentralbl Bakteriol Mikrobiol Hyg A 1982;251:380-8.
  22. Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012;67:62-70. https://doi.org/10.1136/thx.2010.143180
  23. Ringshausen FC, Schablon A, Nienhaus A. Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol 2012;7:6. https://doi.org/10.1186/1745-6673-7-6
  24. Fong KS, Tomford JW, Teixeira L, Fraser TG, van Duin D, Yen-Lieberman B, et al. Challenges of interferon-gamma release assay conversions in serial testing of health-care workers in a TB control program. Chest 2012;142:55-62. https://doi.org/10.1378/chest.11-0992
  25. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Tuberculosis Epidemiologic Studies Consortium. Am J Respir Crit Care Med 2014;189:77-87.
  26. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59:1-25.
  27. National Institute for Health and Clinical Excellence (NICE). Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians of London, 2011.
  28. Van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One 2009;4:e8517. https://doi.org/10.1371/journal.pone.0008517
  29. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011;37:88-99. https://doi.org/10.1183/09031936.00115110
  30. Mulder C, van Deutekom H, Huisman EM, Toumanian S, Koster BF, Meijer-Veldman W, et al. Role of the QuantiFERON (R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection. Eur Respir J 2012;40:1443-9. https://doi.org/10.1183/09031936.00010612
  31. Menzies R, Vissandjee B, Rocher I, St Germain Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med 1994;120:190-8. https://doi.org/10.7326/0003-4819-120-3-199402010-00003
  32. Lee SW, Oh DK, Lee SH, Kang HY, Lee CT, Yim JJ. Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis. Eur Respir J 2011;37:1447-52. https://doi.org/10.1183/09031936.00089510
  33. Balmelli C, Zysset F, Pagnamenta A, Franciola P, Lazor-Blanchet C, Zanetti G, et al. Contact tracing investigation after professional exposure to tuberculosis in a Swiss hospital using both tuberculin skin test and IGRA. Swiss Med Wkly 2014;144:w13988.
  34. Li CY, Chen HC, Cheng HY, Chian CF, Chang FY, Chen HI, et al. Role of QuantiFERON-TB-Gold In Tube assay for active and latent tuberculosis infection in investigation of tuberculosis outbreak in a university. J Microbiol Immunol Infect 2015;48:263-8. https://doi.org/10.1016/j.jmii.2013.08.022
  35. O'Neal S, Hedberg K, Markum A, Schafer S. Discordant tuberculin skin and interferon-gamma tests during contact investigations: a dilemma for tuberculosis controllers. Int J Tuberc Lung Dis 2009;13:662-4.
  36. Nienhaus A, Schablon A, Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection--analysis of discordant results, when compared to the tuberculin skin test. PLoS One 2008;3:e2665. https://doi.org/10.1371/journal.pone.0002665
  37. Lee SS, Liu YC, Huang TS, Chen YS, Tsai HC, Wann SR, et al. Comparison of the interferon-gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Scand J Infect Dis 2008;40:373-80. https://doi.org/10.1080/00365540701730743